On December 6, 2007, Pietro Zorzetto of Padova, Itally was implanted with the SynCardia Total Artificial Heart. He remained on it for 1374 days (nearly 4 years) prior to his successful donor heart transplant on September 11, 2011.
Italian Man Surpasses 1,000 Days of Support with SynCardia's Total Artificial Heart
54-Year-Old Man Enjoys Life at Home with Portable Driver While Waiting for a Matching Donor Heart
TUCSON, Ariz. – Oct. 12, 2010 – A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with the SynCardia temporary Total Artificial Heart while waiting for a matching donor heart.
"Life is a wonderful present that has to be respected," said Total Artificial Heart patient Pietro Zorzetto. "The Total Artificial Heart allowed me to recover to a very healthy physical condition. I really want to thank the SynCardia Total Artificial Heart for these unexpected 1,000 days of life."
Mr. Zorzetto was first admitted to Azienda Ospedaliera di Padova on Nov. 30, 2007, suffering from valvular cardiomyopathy. Two previous operations at a different hospital had failed to repair his failing heart. Less than a week later, on Dec. 6, 2007, Mr. Zorzetto made history when he became the first patient in Italy to be implanted with the SynCardia Total Artificial Heart.
"The Total Artificial Heart provides excellent cardiac output, which restored our patient to normal condition despite the fact he presented with severe multi-organ failure," said Prof. Gino Gerosa. "The Total Artificial Heart in combination with the portable driver has been extremely effective in providing the patient with a good quality of life with excellent exercise capacity."
Mr. Zorzetto has been enjoying life at home since Feb. 4, 2008, when he was discharged from the hospital using a portable driver to power his Total Artificial Heart. On a typical day, he walks 10 km and then exercises for an additional 30 minutes in his gym at home to stay in shape for a transplant.
CAUTION - The Freedom® portable driver is CE approved for commercial use in Europe and is undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
VIDEO: Watch Italian Total Artificial Heart patient Pietro Zorzetto ride his bicycle wearing the Freedom® portable driver in the Backpack. Video may take a few moments to download.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, firstname.lastname@example.org, (520) 547-7463